Overview

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Status:
Recruiting

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

This study is single center single arm prospective phase II study. In this study, efficacy and side effects of pemetrexed as salvage regimen on patients who failed all standard chemotherapy and total of 29 patients will be enrolled. Pemetrexed will be continued until disease progression is happened.

Phase:

Phase 2

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

Erlotinib Hydrochloride
Pemetrexed